综述文章

埃博拉病毒感染的实验室诊断方法研究进展

  • 乔晋娟 ,
  • 罗俊 ,
  • 危宏平
展开
  • 1. 中国科学院武汉病毒研究所新发传染病研究中心, 武汉430071;
    2. 中国科学院大学, 北京100049
乔晋娟, 博士研究生, 研究方向为诊断微生物学, 电子信箱:jjqiao234@sina.com

收稿日期: 2014-08-26

  修回日期: 2014-10-21

  网络出版日期: 2015-02-02

基金资助

中国科学院重点部署项目(KJZD-EW-L02);武汉新发传染病与生物安全重点实验室项目(WHEID-2014004)

Laboratory diagnosis of Ebola virus disease: A review

  • QIAO Jinjuan ,
  • LUO Jun ,
  • WEI Hongping
Expand
  • 1. Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China;
    2. University of Chinese Academy of Sciences, Beijing 100049, China

Received date: 2014-08-26

  Revised date: 2014-10-21

  Online published: 2015-02-02

摘要

埃博拉病毒病是由埃博拉病毒引起的一种急性出血性传染病,具有极高的传染性,病死率高达90%,世界卫生组织已将埃博拉病毒列为对人类危害最严重的病毒之一,目前虽有一个被美国食品和药物管理局(FDA)批准用于紧急治疗的实验药物TKM-Ebola,但尚无批准上市的用于预防埃博拉病毒的疫苗.建立快速、准确、简便的实验室检测方法对及时进行临床诊断救治、开展流行病学调查并最终控制其传播流行具有重要意义.本文综述埃博拉病毒实验室检测方法的原理、应用及进展,介绍病毒分离、电子显微镜观察、逆转录聚合酶链反应法、抗原检测试验、抗体酶联免疫吸附试验、血清中和试验及其他检测方法.

本文引用格式

乔晋娟 , 罗俊 , 危宏平 . 埃博拉病毒感染的实验室诊断方法研究进展[J]. 科技导报, 2015 , 33(1) : 100 -106 . DOI: 10.3981/j.issn.1000-7857.2015.01.018

Abstract

Ebola virus disease (EVD) caused by Ebola viruses (EBOV) is an acute hemorrhagic infectious disease. Because of its high infectivity and high mortality rate(up to 90%), EBOV is listed as one of the most dangerous viruses to human by World Health Organization. Although US FDA gave it emergency clearance to use an experimental drug TKM-Ebola, there is no Ebola vaccine available yet. Rapid, accurate, simple and reliable laboratory diagnostic tests are required in suspected cases for timely treatment, epidemiological investigation and controlling the spread of the EVD. This review summarizes the principles, applications and progress of the laboratory diagnosis of EVD, covering virus isolation by cell culture, electron microscopy, reverse transcriptase polymerase chain reaction (RT-PCR) assay, antigen detection, antibody-capture enzyme-linked immunosorbent assay and serum neutralization test.

参考文献

[1] Pourrut X, Kumulungui B, Wittmann T, et al. The natural history of Ebola virus in Africa[J]. Microbes and infection/Institut Pasteur, 2005, 7 (7-8): 1005-1014.
[2] Zampieri C A, Sullivan N J, Nabel G J. Immunopathology of highly virulent pathogens: Insights from Ebola virus[J]. Nature Immunology, 2007, 8(11): 1159-1164.
[3] Gonzalez J P, Pourrut X, Leroy E. Ebolavirus and other filoviruses[J]. Current Topics in Microbiology and Immunology, 2007, 315: 363-387.
[4] Li Y H, Chen S P. Evolutionary history of Ebola virus[J]. Epidemiology and Infection, 2014, 142(6): 1138-1145.
[5] Morikawa S, Saijo M, Kurane I. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston)[J]. Comparative Immunology, Microbiology and Infectious Diseases, 2007, 30(5-6): 391-398.
[6] Geisbert T W, Jahrling P B. Differentiation of filoviruses by electron microscopy[J]. Virus Research, 1995, 39(2-3): 129-150.
[7] Leguenno B, Formentry P, Wyers M, et al. Isolation and partial characterization of a new strain of Ebola virus[J]. Lancet, 1995, 345 (8960): 1271-1274.
[8] Truant A L, Regnery R L, Kiley M P. Development of an immunofluorescence focus assay for Ebola virus[J]. Journal of Clinical Microbiology, 1983, 18(2): 416-419.
[9] Stroher U, West E, Bugany H, et al. Infection and activation of monocytes by Marburg and Ebola viruses[J]. Journal of Virology, 2001, 75(22): 11025-11033.
[10] Hazelton P R, Gelderblom H R. Electron microscopy for rapid diagnosis of infectious agents in emergent situations[J]. Emerging infectious Diseases, 2003, 9(3): 294-303.
[11] Biel S S, Gelderblom H R. Diagnostic electron microscopy is still a timely and rewarding method[J]. Journal of Clincal Virology, 1999, 13 (1-2): 105-119.
[12] Curry A, Appleton H, Dowsett B. Application of transmission electron microscopy to the clinical study of viral and bacterial infections: Present and future[J]. Micron, 2006, 37(2): 91-106.
[13] Goldsmith C S, Miller S E. Modern uses of electron microscopy for detection of viruses[J]. Clinical Microbiology Reviews, 2009, 22(4): 552-563.
[14] Johnson K M, Lange J V, Webb P A, et al. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire[J]. Lancet, 1977, 1(8011): 569-571.
[15] Bowen E T, Lloyd G, Harris W J, et al. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent[J]. Lancet, 1977, 1(8011): 571-873.
[16] Jahrling P B, Geisbert T W, Dalgard D W, et al. Preliminary report: Isolation of Ebola virus from monkeys imported to USA[J]. Lancet, 1990, 335(8688): 502-505.
[17] Geisbert T W, Jahrling P B. Use of Immunoelectron microscopy to show Ebola virus during the 1989 United-States epizootic[J]. Journal of Clinical Pathology, 1990, 43(10): 813-816.
[18] Geisbert T W, Rhoderick J B, Jahrling P B. Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy[J]. Journal of Clinical Pathology, 1991, 44 (6): 521-522.
[19] Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola vrus disease in Guinea-preliminary report[J]. The New England Journal of Medicine, 2014, 371: 1418-1425.
[20] Alymbayeva D, Kuchuk T, Usmanov R. Diagnosis of viral infections by electron microscopy in Kyrgyzstan[J]. Electron Microscopy, 1994, 3a/3b: 1399-1400.
[21] Rowe A K, Bertolli J, Khan A S, et al. Clinical, virologic, and immunologic follow- up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo[J]. Journal of Infectious Diseases, 1999, 179(Suppl 1): S28- S35.
[22] Leroy E M, Baize S, Lu C Y, et al. Diagnosis of Ebola haemorrhagic fever by RT- PCR in an epidemic setting[J]. Journal of Medical Virology, 2000, 60(4): 463-467.
[23] Formenty P, Leroy E M, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo[J]. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 2006, 42(11): 1521-1526.
[24] Sanchez A, Ksiazek T G, Rollin P E, et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates[J]. Journal of Infectious Diseases, 1999, 179 (Suppl 1): S164-S169.
[25] Towner J S, Rollin P E, Bausch D G, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription- PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome[J]. Journal of Virology, 2004, 78(8): 4330-4341.
[26] Onyango C O, Opoka M L, Ksiazek T G, et al. Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004[J]. Journal of Infectious Diseases, 2007, 196(Suppl 2): S193-S198.
[27] Drosten C, Gottig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR[J]. Journal of Clinical Microbiology, 2002, 40(7): 2323-2330.
[28] Gibb T R, Norwood D A, Woollen N, et al. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan[J]. Journal of Clinical Microbiology, 2001, 39(11): 4125-4130.
[29] 刘阳, 史子学, 马玉堃, 等. SYBR Green Ⅰ荧光定量RT-PCR检测埃 博拉病毒方法的建立[J]. 病毒学报, 2012, 28(5): 567-571. Liu Yang, Shi Zixue, Ma Yukun, et al. Development of SYBR Green Ⅰreal-time RT-PCR for the detection of Ebola[J]. Chinese Journal of Virology, 2012, 28(5): 567-571.
[30] Huang Y, Wei H, Wang Y, et al. Rapid detection of filoviruses by real- time TaqMan polymerase chain reaction assays[J]. Virologica Sinica, 2012, 27(5): 273-277.
[31] 盖微微, 郑学星, 薛向红, 等. 埃博拉病毒检测与分型Real-time PCR 方法的建立[J]. 中国病原生物学杂志, 2013, 8(3): 208-211, 216. Gai Weiwie, Zheng Xuexing, Xue Xianghong, et al. Development of a real-time PCR method to detect and type Ebola virus[J]. Journal of Pathogen Biology, 2013, 8(3): 208-211, 216.
[32] 刘阳, 史子学, 王水明, 等. 一步法MGB荧光定量RT-PCR检测埃博 拉病毒扎伊尔亚型和苏丹亚型方法的建立[J]. 中国人兽共患病学 报, 2012, 28(4): 343-346, 350. Liu Yang, Shi Zixue, Wang Shuiming, et al. Establishment of one step MGB real-time RT-PCR for detection of Ebola virus Zaire and Sudan subtypes[J]. Chinese Journal of Zoonoses, 2012, 28(4): 343-346, 350.
[33] Zhai J, Palacios G, Towner J S, et al. Rapid molecular strategy for filovirus detection and characterization[J]. Journal of Clinical Microbiology, 2007, 45(1): 224-226.
[34] Ogawa H, Miyamoto H, Ebihara H, et al. Detection of all known filovirus species by reverse transcription- polymerase chain reaction using a primer set specific for the viral nucleoprotein gene[J]. Journal of Virological Methods, 2011, 171(1): 310-313.
[35] Kurosaki Y, Takada A, Ebihara H, et al. Rapid and simple detection of Ebola virus by reverse transcription- loop- mediated isothermal amplification[J]. Journal of Virological Methods, 2007, 141(1): 78-83.
[36] Ksiazek T G, Rollin P E, Jahrling P B, et al. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates[J]. Journal of Clinical Microbiology, 1992, 30(4): 947-950.
[37] Lucht A, Grunow R, Moller P, et al. Development, characterization and use of monoclonal VP40- antibodies for the detection of Ebola virus[J]. Journal of Virological Methods, 2003, 111(1): 21-28.
[38] Lucht A, Grunow R, Otterbein C, et al. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus[J]. Medical Microbiology and Immunology, 2004, 193(4): 181-187.
[39] Saijo M, Niikura M, Maeda A, et al. Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay[J]. Journal of Medical Virology, 2005, 76(1): 111-118.
[40] Lucht A, Formenty P, Feldmann H, et al. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection[J]. Journal of Infectious Diseases, 2007, 196 (Suppl 2): S184-S192.
[41] Saijo M, Niikura M, Morikawa S, et al. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins[J]. Journal of Clinical Microbiology, 2001, 39(1): 1-7.
[42] Saijo M, Niikura M, Ikegami T, et al. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins[J]. Clinical and Vaccine Immunology: CVI, 2006, 13(4): 444-451.
[43] 王淑杰, 王喜军, 胡森, 等. 抗埃博拉病毒VP40蛋白单克隆抗体的制 备及在抗原捕捉ELISA中的应用[J]. 中国预防兽医学报, 2008, 30 (4): 309-313. Wang Shujie, Wang Xijun, Hu Sen, et al. Development of an antigen capture ELISA against VP40 protein of Ebola virus using monoclonal antibodies[J]. Chinese Journal of Preventive Veterinary Medicine, 30 (4): 309-313.
[44] 王晓杜, 刘阳, 王皓婷, 等. 埃博拉病毒NP蛋白的单克隆抗体制备及 抗原肽的定位[J]. 生物工程学报, 2012, 28(11): 1317-27. Wang Xiaodu, Liu Yang, Wang Haoting, et al. Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus[J]. Chinese Journal of Biotechnology, 2012, 28(11): 1317-1327.
[45] Ikegami T, Niikura M, Saijo M, et al. Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein[J]. Clinical and Diagnostic Laboratory Immunology, 2003, 10(4): 552-557.
[46] Niikura M, Ikegami T, Saijo M, et al. Detection of Ebola viral antigen by enzyme- linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein[J]. Journal of Clinical Microbiology, 2001, 39 (9): 3267-3271.
[47] Sherwood L J, Hayhurst A. Ebolavirus Nucleoprotein C- Termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation[J]. Plos One, 2013, 8 (4): e61232.
[48] Zaki S R, Shieh W J, Greer P W, et al. A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit[J]. Journal of Infectious Diseases, 1999, 179 (Suppl 1): S36-S47.
[49] Prehaud C, Hellebrand E, Coudrier D, et al. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections[J]. The Journal of General Virology, 1998, 79 (Pt11): 2565-2572.
[50] Ikegami T, Saijo M, Niikura M, et al. Immunoglobulin G enzymelinked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus[J]. Epidemiology and Infection, 2003, 130(3): 533-539.
[51] Groen J, van den Hoogen B G, Burghoorn- Maas C P, et al. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins[J]. Microbes and Infection, 2003, 5(5): 379-385.
[52] 盖微微, 郑学星, 薛向红,等. 埃博拉病毒VP40蛋白的原核表达及其 抗体间接ELISA检测方法的建立[J]. 中国病原生物学杂志, 2013, 8 (9): 782-786. Gai Weiwei, Zheng Xuexing, Xue Xianghong, et al. Expression of the VP40 gene of Ebola virus and development of recombinant proteinbased indirect ELISA[J]. Journal of Pathogen Biology, 2013, 8(9): 782- 786.
[53] Saijo M, Niikura M, Morikawa S, et al. Immunofluorescence method for detection of Ebola virus immunoglobulin G, using HeLa cells which express recombinant nucleoprotein[J]. Journal of Clinical microbiology, 2001, 39(2): 776-778.
[54] Ikegami T, Saijo M, Niikura M, et al. Development of an immunofluorescence method for the detection of antibodies to Ebola virus subtype Reston by the use of recombinant nucleoproteinexpressing HeLa cells[J]. Microbiology and Immunology, 2002, 46(9): 633-638.
[55] MacNeil A, Reed Z, Rollin P E. Serologic cross-reactivity of human IgM and IgG Antibodies to five species of Ebola Virus[J]. Plos Neglect Trop D, 2011, 5(6): e1175.
[56] Nidom C A, Nakayama E, Nidom R V, et al. Serological evidence of Ebola virus infection in indonesian orangutans[J]. Plos One, 2012, 7 (7): e40740.
[57] Manicassamy B, Wang J, Jiang H, et al. Comprehensive analysis of ebola virus GP1 in viral entry[J]. Journal of Virology, 2005, 79(8): 4793-4805.
[58] Vanderzanden L, Bray M, Fuller D, et al. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge[J]. Virology, 1998, 246(1): 134-144.
[59] Maruyama T, Rodriguez L L, Jahrling P B, et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection[J]. Journal of virology, 1999, 73(7): 6024-6030.
[60] 夏文英, 郑夔, 黄吉城, 等. 埃博拉病毒检测基因芯片的制备初探[J]. 中国国境卫生检疫杂志, 2011, 34(3): 150-154. Xia Wenying, Zheng Kui, Huang Jicheng, et al. Preliminary preparation of microarray for detecting Ebola virus[J]. Chinese Frontier Health Quarantine, 2011, 34(3): 150-154.
[61] 黄吉城, 郑夔, 王洪敏, 等. 多种病毒集合检测芯片的研制及其在临 床血清标本检测中的初步应用[J]. 中华疾病控制杂志, 2012, 16(4): 297-300. Huang Jicheng, Zheng Kui, Wang Hongmin, et al. Research on microarray for simultaneous detection of multiplex viruses and primary application on detection of clinical serum specimens[J]. Chinese Journal of Disease Control and Prevention, 2012, 16(4): 297- 300.
[62] 欧青叶, 顾大勇, 胡春凌, 等. 8种重大烈性传染病病毒液相芯片检测 方法的建立[J]. 中国国境卫生检疫杂志, 2012, 35(4): 222-227, 234. Ou Qingye, Gu Dayong, Hu Chunling, et al. Development of a luminex liquid chip technology for detection of eight kinds of deadly infectious virus[J]. Chinese Frontier Health Quarantine, 2012, 35(4): 222-227, 234.
[63] Gire S K, Goba A, Andersen K G, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak[J]. Science, 2014, 345(6202): 1369-1372.
文章导航

/